FollowMyHealth Patient Portal

Richard G. Bach, MD, FACC

Professor, Medicine
Division of Cardiovascular Diseases
Director, Cardiac Intensive Care Unit

Specialty Areas

Cardiovascular Disease
Interventional Cardiology
Cardiac Catheterization
Hypertrophic Cardiomyopathy

Board Certifications

Interventional Cardiology
Cardiovascular Disease
Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Referral Information

Physician Referral Required

Areas of Clinical Interest

Interventional cardiology, coronary angioplasty, atherectomy and stenting, valvuloplasty, peripheral intervention, percutaneous atrial septal defect closure, transcoronary alcohol septal ablation for HCM, cardiac catheterization hypertrophic cardiomyopathy with obstruction, coronary ultrasonographic and physiologic assessment, cardiac critical care

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Office Phone: 314-362-2284

Center for Advanced Medicine
Heart & Vascular Center

4921 Parkview Place
St. Louis, MO 63110

Suite: A
Floor: 8
Office Phone: 314-362-1291
Fax: 314-362-4278

Education

Education

Fellowship: Cardiac Catheterization and Angioplasty, NYU Medical Center Bellevue Hospital, New York, New York 1991
Fellowship: Clinical, Cardiology, New York University Medical Center Bellevue Hospital, New York, New York 1990
Fellowship: Research, Cardiology, New York University Medical Center, Bellevue Hospital, New York, New York 1988
Residency: Medicine, New York University School of Medicine, New York, New York 1987
Medical Degree: New York University School of Medicine, New York, New York 1984
B.S.: Biological Sciences, Georgetown University, Washington D.C. 1977

Publication & Research

Publication & Research

Predicting long-term bleeding after percutaneous coronary intervention.
Sharma PK, Chhatriwalla AK, Cohen DJ, Jang JS, Baweja P, Gosch K, Jones P, Bach RG, Arnold SV, Spertus JA
Catheter Cardiovasc Interv. 2016 Apr 1; doi: 10.1002/ccd.26529.

PMID:
    27037854
    [PubMed - as supplied by publisher]
Related citations


Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.
Amin AP, Wang TY, McCoy L, Bach RG, Effron MB, Peterson ED, Cohen DJ
J Am Coll Cardiol. 2016 Jan 5; 67(1)59-65. doi: 10.1016/j.jacc.2015.10.034.

PMID:
    26764067
    [PubMed - indexed for MEDLINE]
Related citations


Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis.
Sintek MA, Sparrow CT, Mikuls TR, Lindley KJ, Bach RG, Kurz HI, Novak E, Singh J
Heart. 2016 Mar; 102(5)363-9. doi: 10.1136/heartjnl-2015-308634.

PMID:
    26719360
    [PubMed - indexed for MEDLINE]
Related citations


Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients.
Taha S, D'Ascenzo F, Moretti C, Omedè P, Montefusco A, Bach RG, Alexander KP, Mehran R, Ariza-Solé A, Zoccai GB, Gaita F
Postepy Kardiol Interwencyjnej. 2015; 11(3)182-90. doi: 10.5114/pwki.2015.54011.

PMID:
    26677357
    [PubMed]
Related citations


Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome.
Masrani Mehta S, Depta JP, Novak E, Patel JS, Patel Y, Raymer D, Facey G, Zajarias A, Lasala JM, Singh J, Bach RG, Kurz HI
J Am Heart Assoc. 2015 Aug 19; 4(8)e002172. doi: 10.1161/JAHA.115.002172.

PMID:
    26289346
    [PubMed - indexed for MEDLINE]
Related citations


Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
Sintek MA, Gdowski M, Lindman BR, Nassif M, Lavine KJ, Novak E, Bach RG, Silvestry SC, Mann DL, Joseph SM
J Card Fail. 2015 Nov; 21(11)868-76. doi: 10.1016/j.cardfail.2015.06.383.

PMID:
    26164215
    [PubMed - indexed for MEDLINE]
Related citations


Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Xian Y, Wang TY, McCoy LA, Effron MB, Henry TD, Bach RG, Zettler ME, Baker BA, Fonarow GC, Peterson ED
Circulation. 2015 Jul 21; 132(3)174-81. doi: 10.1161/CIRCULATIONAHA.114.014992.

PMID:
    25995313
    [PubMed - indexed for MEDLINE]
Related citations


ACP Journal Club: review: periprocedural high-dose statins reduce contrast-induced acute kidney injury after coronary angiography.
Bach RG
Ann Intern Med. 2015 Feb 17; 162(4)JC4. doi: 10.7326/ACPJC-2015-162-4-004.

PMID:
    25686191
    [PubMed - indexed for MEDLINE]
Related citations


Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment.
Depta JP, Patel JS, Novak E, Gage BF, Masrani SK, Raymer D, Facey G, Patel Y, Zajarias A, Lasala JM, Amin AP, Kurz HI, Singh J, Bach RG
Eur Heart J. 2015 Feb 21; 36(8)509-15. doi: 10.1093/eurheartj/ehu412.

PMID:
    25336221
    [PubMed - indexed for MEDLINE]
Related citations


Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.
Depta JP, Lenzini PA, Lanfear DE, Wang TY, Spertus JA, Bach RG, Cresci S
Pharmacogenomics J. 2015 Feb; 15(1)20-5. doi: 10.1038/tpj.2014.28.

PMID:
    25001880
    [PubMed - indexed for MEDLINE]
Related citations


Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve values.
Depta JP, Patel JS, Novak E, Masrani SK, Raymer D, Facey G, Patel Y, Zajarias A, Lasala JM, Singh J, Bach RG, Kurz HI
Am J Cardiol. 2014 Jun 1; 113(11)1788-93. doi: 10.1016/j.amjcard.2014.03.004.

PMID:
    24837255
    [PubMed - indexed for MEDLINE]
Related citations


Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.
Cresci S, Depta JP, Lenzini PA, Li AY, Lanfear DE, Province MA, Spertus JA, Bach RG
Circ Cardiovasc Genet. 2014 Jun; 7(3)277-86. doi: 10.1161/CIRCGENETICS.113.000303.

PMID:
    24762860
    [PubMed - indexed for MEDLINE]
Related citations


Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL, BARI 2D Investigators
Circulation. 2014 Apr 22; 129(16)e460-1. doi: 10.1161/CIRCULATIONAHA.113.008033.

PMID:
    24753557
    [PubMed - indexed for MEDLINE]
Related citations


CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.
Chen LS, Bach RG, Lenzini PA, Spertus JA, Bierut LJ, Cresci S
Nicotine Tob Res. 2014 Sep; 16(9)1224-31. doi: 10.1093/ntr/ntu059.

PMID:
    24727484
    [PubMed - indexed for MEDLINE]
Related citations


The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg PG, Storey RF, Wojdyla D, Wallentin L, PLATO study group
Eur Heart J. 2014 Jun 14; 35(23)1541-50. doi: 10.1093/eurheartj/ehu075.

PMID:
    24682844
    [PubMed - indexed for MEDLINE]
Related citations


Conversations in cardiology: bridging antiplatelet therapy before surgery.
Kern MJ, Applegate RJ, Bell M, Brilakis ES, Butman SM, Bach RG, Kaul P, Klein LW, Krucoff MW, Moore JA, Price MJ, Rao SV, Stone GW, Uretsky BF
Catheter Cardiovasc Interv. 2014 Apr 1; 83(5)748-52. doi: 10.1002/ccd.25319.

PMID:
    24395180
    [PubMed - indexed for MEDLINE]
Related citations


Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL, BARI 2D Investigators
Circulation. 2013 Aug 20; 128(8)785-94. doi: 10.1161/CIRCULATIONAHA.112.000678.

PMID:
    23857320
    [PubMed - indexed for MEDLINE]
Related citations


ACP Journal Club. SYNTAX score II predicted mortality after PCI or CABG in complex CAD better than SYNTAX score.
Bach RG
Ann Intern Med. 2013 Jul 16; 159(2)JC5. doi: 10.7326/0003-4819-159-2-201307160-02005.

PMID:
    23856703
    [PubMed - indexed for MEDLINE]
Related citations


ACP Journal Club. PCI was not as effective as CABG for severe coronary artery disease at 5 years.
Bach RG
Ann Intern Med. 2013 Jul 16; 159(2)JC4-5. doi: 10.7326/0003-4819-159-2-201307160-02004.

PMID:
    23856702
    [PubMed - indexed for MEDLINE]
Related citations


Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions.
Patel Y, Depta JP, Patel JS, Masrani SK, Novak E, Zajarias A, Kurz HI, Lasala JM, Bach RG, Singh J
Catheter Cardiovasc Interv. 2016 Feb 1; 87(2)232-40. doi: 10.1002/ccd.25034.

PMID:
    23728924
    [PubMed - in process]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2015.

Company Name: Eli Lilly

Royalties:

Equity: No

Consulting/Advisory Board: $10,001 - $25,000

Speaker Fees:

Reporting Date: May 01, 2016


Company Name: NovoNordisk

Royalties:

Equity: No

Consulting/Advisory Board: $100,001 - $200,000

Speaker Fees:

Reporting Date: May 01, 2016

Notes

Financial Disclosure: Dr. Bach’s consulting activities consist only of Clinical Event Adjudication Committee activities for clinical trials.

Areas of Research Interest

Clinical investigation in acute coronary syndromes: In the cardiac intensive care unit, my group has focused on the clinical investigation of outcomes and promising therapies for patients with acute myocardial infarction (AMI) and acute coronary syndromes (ACS).  Coronary intervention and coronary physiology: Another of my primary research interests involves interventional cardiology, with pre-clinical and clinical studies in the use of magnetic navigation via the Stereotaxis Niobe system to facilitate coronary intervention; Hypertrophic cardiomyopathy: For symptomatic patients with left ventricular outflow tract obstruction due to hypertrophic obstructive cardiomyopathy, a catheter-based method of non-surgical septal reduction by alcohol septal ablation can provide significant symptomatic improvement. To better understand the short and long-term benefits of transcatheter alcohol septal ablation, we are studying its effects on cardiac remodeling and coronary and myocardial physiology. In addition, via collaborative translational echocardiographic and genetic studies, we are interested in exploring the gene polymorphisms that contribute to the wide phenotypic anatomic and physiologic variability among patients and family members with hypertrophic cardiomyopathy